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Abstract
Objectives: The aim of the present study was to evaluate the effect of Erythrina mulungu on the control of dental 
anxiety in patients who had under gone bilateral extraction of asymptomatic, impacted mandibular third molars. 
Material and Methods: In a randomized, double-blind, crossover study, 30 healthy volunteers (5 men and 25 wom-
en, over 18 years of age), received either 500mg of E.mulungu (Mulungu Matusa®) or 500 mg of placebo, p.o., one 
hour before surgical procedure. The level ofanxiety was assessed through questionnaire sand physical parameters, 
such as blood pressure, heart rate andoxygen saturation. Data were analyzed by Chi-square test, ANOVA (Tukey 
test) and Friedman with significance level of 5%. 
Results: A higher preference (Chi-square, p = 0.0062) for E. mulungu was observed for both genders. Volunteers 
with higher anxiety levels tended to to prefer E. mulungu. No statistically significant differences were verified in 
blood pressure (one-way ANOVA, p = 0.1259), heart rate (Friedman, p> 0.05) and oxygen saturation (Friedman, p 
= 0.7664) among periods and types of treatments. 
Conclusions: E. mulungu showed an anxiolytic effect without significant changes in physiological parameters. It 
could be considered as an alternative to control the anxiety in adult patients undergoing mandibular thirdmolars 
surgery.
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Introduction
From the simplest procedure to a more invasive one, such 
as surgery, anxiety is a common problem faced in the 
dentist office.When these feelings of anxiety and fear oc-
cur due to the prospect of dental treatment, it is known 
as dental anxiety (1,2). Fear and anxiety about dental 
treatment are important clinical problems and they occur 
in 40-50% of the general population (3). Among dental 
procedures, minor oral surgeries tend to cause a lot of 
anxiety to patients because they are linked to the pos-
sibility of pain. The surgery to remove the third molaris 
considered the most dreadful for patients, even higher 
than those surgeries performed toremove hard and soft 
tissue from injuries or insertion of implants (4).
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The emotional and psychological states of the patient 
can affect treatment, impair the absorption of drugs, or 
even cause undesirable physiological changes (2). Thus, 
fears, phobias, stressful situations and depression can 
often alter the physiological functions of the body, re-
duce the excitability threshold (making the body feel 
more pain), alter the immune response, and have a nega-
tive impact on the trans and postoperative periods (4).
Given the fact that the dentist is routinely in contact 
with anxious patients, methods for controlling anxiety 
are used when such condition can alter the performance 
of a safe and quality procedure. Anxiety can be control-
led by both pharmacological and non-pharmacological 
methods. For this, the most used method is the verbali-
zation one, where the dentist should be able to under-
stand, guide, soothe and comfort the patient regarding 
the procedures to be performed.When this is not enough, 
pharmacological methods are used, such as anxioly-
tics, which act reducing anxiety. Benzodiazepines are 
the most commonly used anxiolytics (5). However, they 
have important side effects. Patients using benzodi-
azepines can not go unaccompanied to a consultation, 
drive or operate machinery duringtreatment.
Because of the difficulties with the use of this group of 
drugs, one may resort to the use of herbal medicines. 
These are substances obtained from plants, which can 
be used as handmade medicines in the form of teas, so-
lutions orpills (6).
Erythrina mulungu, a Southern Brazilian native plant 
which produces alkaloids and steroids, is a herbal medi-
cine known for its good control of anxiety. Popularly 
known asmulungu (7), Erythrina mulungu is a medium-
sized tree found in tropical regions and itsbark and seed 
have been used in folk medicine due to their anticon-
vulsant, analgesic, sedative, hypnotic and hypotensive 
properties (8).
Studies in mice and rats show that water-alcoholic ex-
tracts of E. mulungu are central nervous system depres-
sants, they alter the responses related to anxiety, but 
they do not affect motor coordination (6-8). Although 
the benefits of anxiolytic effects of the E. mulungu can 
be applied to the dental clinic for anxiety reduction 
without presenting the constraints of benzodiazepines, 
there is a dearth of research on the use of this plant for 
the control of dental anxiety. Thus, this study aimed to 
assess the efficacy of E. mulungu in controlling anxiety 
during dental procedure.
Material and Methods
The study was submitted for review and approval to 
the University Hospital Research Ethics Committee 
of the Federal University of Sergipeby the protocol 
CEP 401/2011 and CAAE number 0366.0.107.000-11-
,in a meeting held on 07/12/2011, and consort number 
NCT01948622. In this research, characterized as a ran-
domized, double-blind, crossover study, 30 volunteered 
patients from the Department of Dentistry of the Fe-
deral University of Sergipe (DOD/UFS) were selected, 
after diagnosis and indication of bilateral extraction 
of asymptomatic, impacted mandibular third molars, 
according to Pell and Gregory classification used by 
Almendros-Marqués, Berini-Aytés & Gay-Escoda (9). 
This method classifies mandibular third molars into 
9 different categories based on their vertical position 
(relative tothe cementoenamel junction and the occlusal 
plane) and their horizontal position (relative to the as-
cending mandibular ramus).
All participants were informed of both risks and benefits 
of the study, and signed an informed consent. Exclusion 
criteria were: patients under the age of 18; any general 
health problem based on the medical history and physi-
cal examination; history of use of any medication within 
15 days before the beginning of the research; history of 
hypersensitivity to drugs, substances or materials used 
in this experiment; pregnancy or lactation; history of 
pericoronitis.
The study participants randomly received either Mu-
lungu Matusa® 500 mg (two capsules of 250 mg each) 
or placebo (starch, two capsules), orally one hour be-
fore the start of surgical procedures, at either the first or 
second intervention (right or left side). It is noteworthy 
that both the placebo and the capsule of Erytrina mu-
lungu were absolutely equal in size and shape. The drug 
was given to the patient by the first researcher, coded as 
“Protocol 1” or “Protocol 2”. Both protocols were only 
identified at the end of the experiment. Randomization 
was done with Random Number Generator Pro 2.15 
software and it was established that 15 patients received 
“Protocol 1” and 15 patients received “Protocol 2” in 
the first surgery.Therefore, everyone involved in the re-
search, volunteers, surgeon and researcher, had no prior 
knowledge of pharmacological treatments thatwere be-
ing used (double-blind study).
In order to avoid the pain and swelling after surgery, 
a single dose of intramuscular dexamethasone (8mg), 
30 minutes before surgery, was administered. Before 
the surgery, oral antisepsis was performed by vigor-
ous rinsing, for one minute, with an aqueous solution of 
chlorhexidinedigluconate (0.12%). In the extra-oral an-
tiseptisis, an alcoholic solution of polyvinylpyrrolidone-
iodine (PVP-I) 10% was used.
Local anesthesia was performed using the Vazirani-
Akinosi mandibular nerve block technique, according 
to Haas (10), which consists of positioning the needle 
tip in the pterygomandibular space. For this blockade, 
one cartridge (1.8 ml) of 2% lidocaine with 1:100,000 of 
epinephrine was used. The needle was insertedinto the 
tissue in the distobuccal vestibule opposite thesecond 
or third mandibular molar just medial to the coronoid 
notch until bone was contacted and 0.25 mL of artic-
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aine (4%) with 1:100,000 of epinephrine was released, 
only then the buccal nerve was anesthetized, according 
to Reed et al. (11).
Surgical procedures occurred in two sessions, one for 
each side of the hemi-jaw. Extractions of impacted 
mandibular third molars were done by the operator, a 
maxillofacial surgeon from the DOD/UFS. The surgi-
cal technique used was performed according to Jansma 
et al. (12).
Patients were instructed for local hemostatic care, feed-
ing, cleaning the operated region, restriction of physical 
exertion, and other routine recommendations usually 
given in this type of intervention. In the following day 
of each tooth extraction, a local application of aqueous 
chlorhexidinedigluconate 0.12% for the dental plaque 
control, every 12 hours for 7 days, was recommended. 
The suture was removed on the seventh day. The volun-
teers also received three tablets of 750 mg paracetamol, 
as analgesic medication, being advised to take one tab-
let every 6 hours only if pain. The minimum interval 
between the first and second surgery was 15 days.
The assessment of the subjects’ anxiety levelwas con-
ducted through questionnaires and physical parameters, 
and it wasdivided into three phases: Phase I (baseline), 
Phase II (day of surgery) and Phase III (return visit).
-Phase I - baseline: during the initial consultation, a week 
before the day scheduled for the first intervention,the 
Modified Corah Dental Anxiety Scale was used. The 
scaleconsists of a questionnaire with four questions, 
each with five possible answers, which evaluates the 
feelings, signs and reactions of patients related to dental 
treatment. Each alternative response received a certain 
score (1-5), and, ultimately, the patients were classified 
according to their level of anxiety based on the sum 
of these points as: very little anxious, mildly anxious, 
moderately anxious and very anxious. The terminology 
used in the questions was adapted to the needs of the 
research.
-Phase II -the day of surgery: the level of anxiety was 
assessed by the second researcher and the operator re-
sponsible for the surgery, who answered questions of the 
same questionnaire at the end of each surgery. In this 
questionnaire,both the researcher and operator classified 
the patient as quiet, moderately anxious or very anxious 
and, in the case of patients moderately or very anxious, 
it was necessary to answer in which surgical time this 
happened (at the momenthe/she entered the operating 
room, during antisepsis, anesthesia, surgery itself or in 
end of the procedure). In addition to responding the ques-
tionnaire, the second researcher tabulated data from the 
evaluation of blood pressure (mmHg), heart rate (bpm) 
and the level of oxygen saturation (SpO2) before drug ad-
ministration, 30 minutes after drug administration and 
during the following surgical times: local anesthesia, in-
cision, tooth removal and suturing.
-Phase III - return visit: after each surgical procedure, 
the volunteers received a self assessment form, to be 
answered in the days following the surgery. They were 
supposed to answer if they were tranquil, moderately 
anxious or very anxious. And also if they rememberede 
very thing from the surgery, the majority of events,some 
particular time, almost nothing or nothing at all, with 
the purpose of expressing the presence or absence of 
anterograde amnesia. The presence of possible side ef-
fects from the medication used in this study was also 
questioned. Upon completion of the second surgery, 
they answeredwhich procedure they preferred, if the 
first or the second surgery.
After data collection, they were tabulated and analyzed 
by the following statistical tests: chi-square, t-test, 
ANOVA and Tukey test, Friedman, Fisher’s exact test 
with significance level of 5%.
Results
There were 30 volunteers, 25 females with mean age 
(standard deviation) of 22.4 (3.6) years; and 5 males 
with mean age of 22.6 (4.0) years. There were no sta-
tistically significant age differences (t test, p = 0.9296) 
among genders (Fig. 1).
Charts from 1 to 3 show, respectively, the measures of 
blood pressure, heart rate and SpO2. There were no sta-
tistically significant differences (one-way ANOVA, p = 
0.1259) neither among groups nor among the times, re-
garding the systolic pressure. Diastolic blood pressure did 
not show significant statistical differences among groups, 
but there was a significant increase (ANOVA, Tukey, p 
<0.05) during tooth removal in both groups (Fig. 2).
Considering the heart rate, it was observed that there 
was no significant statistical differences among groups 
(Friedman, p> 0.05), but there was significant statistical 
differences among the times studied. Thus, there was 
a significant increase in heart rate during the incision, 
which remained elevated until the suture was done for 
both groups (Fig. 3).
There was also no significant statistical differences 
(Friedman, p = 0.7664) among groups or times regard-
ing SpO2.
Table 1 shows the distribution of patients regarding the 
anxiety level perceived by the operator, the researcher 
and the patient. There was no distribution among the 
perception of the operator and the researcher, therefore 
the data were pooled. It could be observed that there 
were nostatistically significant differences (Fisher’s ex-
act test, p> 0.05) among the relative distributions ob-
served in each group.
Table 2 shows the relative distribution of perceived anx-
iety assessed by the operator/researcher and the patient. 
As it can be observed in the refered table, the perception 
of the patient’s anxiety by the operator/researcher was 
the same as the patient in 50% of cases.
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Fig. 1. Mean (standard deviation) of systolic and diastolic blood pressure.
Fig. 2. Median (interquartile range) of the heart rate.
Table 3 shows the surgery moment when patients re-
ported anxiety. There were no differences between the 
operative times reported by patients as a point of anxi-
ety for both groups. 
Table 4 shows the preference either for E. mulungu or 
the placebo by gender or by their stated anxiety level. In 
general, we observed a greater preference (Chi-square, p 
= 0.0062) for E. mulungu in both genders. Besides that, 
the higher the anxiety level, the greater the tendency to 
prefer E. mulungu.
Discussion
Minor oral surgery under local anesthesia is a common 
procedure and has a relatively short period of recovery, 
but its physical and psychological impacts make it a 
stressful experience (13). Patients undergoing oral max-
illofacial surgery showed higher levels of anxiety com-
pared to those who underwent other types of surgery, 
such as gastrointestinal disorders (14). The anxiety con-
trolin dental surgical procedures proves to be of great 
value, as the level of anxiety can alter the postoperative 
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Fig. 3. Median (interquartile range) of SpO2.
Evaluated Anxiety Control
n (%)
E. mulungu
n (%)
Researcher/operator Tranquil 18 (42.9) 24 (57.1)
Moderately anxious 9 (60) 6 (40)
Very anxious 3 (100) 0
Pacient Tranquil 11 (52.4) 10 (47.6)
Moderately anxious 14 (53.8) 12 (46.2)
Very anxious 5 (38.5) 8 (61.5)
Patient n (%)
Operator/researcher
n (%)
Tranquil Moderately 
anxious
Very 
anxious
Total
Tranquil 18 (42.9) 21 (50) 3 (7.1) 42 (100)
Moderately anxious 2 (13.3) 5 (33.3) 8 (53.3) 15 (100)
Very anxious 1 (33.3) (0) 2 (66.7) 3 (100)
Total 21 (35) 26 (43.3) 13 (21.7) 60 (100)
Table 1. Anxiety level perceived by the operator, the researcher and the patient.
Table 2. Distribution of perceived anxiety assessed by the operator / researcher and the patient.
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Control E. mulungu Total
It does notapply 19 (44.2%) 24 (55.8%) 43 (100%)
Local anesthesia 1 (50%) 1 (50%) 2 (100%)
Local anesthesiaandsurgery 2 (50%) 2 (50%) 4 (100%)
Local anesthesia and surgery and the 
end of the appointment
1 (100%) (0%) 1 (100%)
Surgery 4 (66.7%) 2 (33.3%) 6 (100%)
Surgery and the end of the appointment 2 (100%) (0%) 2 (100%)
When one entered in the surgical room 
and Antisepsis and local anesthesia 
1 (50%) 1 (50%) 2 (100%)
Total 30 (50%) 30 (50%) 60 (100%)
Table 3. Surgery moment when patients reported anxiety.
E. mulungu Placebo Total
Female 19 (76%) 6 (24%) 25 (100%)
Male 4 (80%) 1 (20%) 5 (100%)
Very little anxious 3 (60%) 2 (40%) 5 (100%)
Mildly anxious 9 (81.8%) 2 (18.2%) 11 (100%)
Moderately anxious 6 (66.7%) 3 (33.3%) 9 (100%)
Very anxious 5 (100%) 0 (0%) 5 (100%)
Table 4. Preference for E. mulungu or placebo by gender of individuals or of their stated 
anxiety level.
comfort of the patient. Thus, preoperative anxiety is an 
accurate indicator of postoperative pain and recovery 
after oral surgery (15).
The anxiety level of the subjects who participated in 
this study during dental treatment was measured by the 
Modified Corah Dental Anxiety Scale. This scale has 
been used in several studies (16-20) for its simplicity to 
be applied, for allowing adaptation in the translation of 
the questions and answers of the questionnaire to the 
native language and for the fact that it shows validity 
and reliability for obtaining results.
The present study evaluated the anxiolytic effect of E. 
mulungu for surgical removal of mandibular third mo-
lars. E. mulungu has been used in herbal compositions 
and medicines in Brazil and in the United States for its 
actions in the central nervous system (21,22). We cho-
seto use the E. mulungu due to the fact that its extracts 
are already used in Brazilian folk medicine because of 
its anticonvulsant, antidepressant, analgesic, sedative, 
hypnotic, and hypotensive effects (21,22).
The anxiety level of patients and the effectiveness of the 
treatments were evaluated by the researcher and by the 
surgeon on the day of the intervention (Phase II). In the 
perspective of these observers, the results indicate that 
patients appeared to be more relaxed when the protocol 
used was the one with E. mulungu. Furthermore, the 
uniformity of opinion between the researcher and op-
erator can validate the method of the applied evaluation, 
since both did not know what protocol was being used 
at the time of surgery. Subsequently, the patients were 
asked about which surgery they felt more comfortable 
with during the Phase III of the research. Most patients 
reported a preference for protocol with E. mulungu. It 
was also observed that the higher the level of anxiety, 
according to the Modified Corah Dental Anxiety Scale, 
the higher the preference for protocol with E. mulungu.
The high preference for protocol with E. mulungu can 
be explained by the anxiolytic effects found in the ex-
tracts of this plant in animals conducted studies. Studies 
in rats and monkeys have shown that acute or chronic 
doses of E. mulungu have anxiolytic effects (6,7,21,23). 
Yet, researches indicate that the anxiolytic effect of E. 
mulungu is not associated with motor abnormalities 
(6,21,23). None of the volunteers involved in the study 
showed motor impairment, and drowsiness was the only 
side effect reported by some patients during the protocol 
with E. mulungu. The permanence of motor reflexes can 
be considered a major advantage of the use of this natu-
ral anxiolytic in comparison with the anxiolytic com-
monly employed in dentistry, such as benzodiazepines, 
that cause motor disorders and thus require that patients 
come accompanied to the surgical procedure.
No differences were found among the values of blood 
pressure, heart rate and oxygen concentration between 
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the two groups evaluated in this study. However, there are 
reports that E. mulungu presents hypotensive effect (21). 
The maintenance of the oxygen concentration may also be 
considered an advantage of E. mulungu compared to ben-
zodiazepines, which can cause respiratory depression.
Studies conducted in monkeys with water-alcoholicex-
tracts of E. mulungu indicate the presence of anti-con-
traceptives effects, because of an action on the spinal 
level, which explains the popular use of this plant in or-
der to obtain analgesic effects (8). This analgesic prop-
erty can influence in a more comfortable postoperative 
period after dental surgical procedures.
The use of E. mulungu provided a quieter surgical pro-
cedure for most patients. As it was mentioned on the 
results, the higher the level of the patient’s anxiety, the 
higher the preference for the protocol with E. mulungu. 
Therefore, the use of this natural anxiolytic in anxious 
patients may be advantageous, besides the fact that they 
do not cause respiratory depression and motor abnor-
malities. However, as there is a lack of studies in hu-
mans, it is not possible to confirm the results found. It 
is important to confirm results, so that we can be able 
to test optimal dosages and to refine research models 
to assess clinically the anxiety during dental treatment 
and its pharmacological control.
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